Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALTHEQUITY, INC. Director's Dealing 2018

Mar 29, 2018

30722_dirs_2018-03-29_95183215-bd70-4663-a4a2-932029988f73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2018-03-27

Reporting Person: Soldan Jon (Exec VP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-27 Common Stock A 3781 Acquired 9433 Direct
2018-03-27 Common Stock F 418 $63.50 Disposed 9015 Direct
2018-03-28 Common Stock S 995 $61.30 Disposed 8020 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $28.69 2025-08-26 Common Stock (50000) 50000 Direct
Stock Option (right to buy) $24.36 2026-03-23 Common Stock (12500) 12500 Direct

Footnotes

F1: Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 946 shares on March 27, 2019, and in three equal installments of 945 shares on March 27, 2020, 2021 and 2022.

F2: The option becomes exercisable in two equal installments of 25,000 on August 26, 2018 and 2019.

F3: The option becomes exercisable in two equal annual installments of 6,250 shares on March 23, 2019 and 2020.